3,4-dihydro-5-(4-(1-piperidinyl)butoxy)-1(2H)-isoquinolinone,
129075-73-6,
dpq,
UNII-5007H57E2L,
1(2H)-Isoquinolinone, 3,4-dihydro-5-[4-(1-piperidinyl)butoxy]-,
CHEMBL127336,
5007H57E2L,
3,4-dihydro-5-(4-(1-piperidinyl)butoxy)-1(2H)-isoquinolinone,
5-[4-(Piperidin-1-Yl)butoxy]-3,4-Dihydroisoquinolin-1(2h)-One,
5-[4-(1-Piperidinyl)-butyloxy]-1,2,3,4-tetrahydroisoquinolin-1-one,
3,4-dihydro-5-[4-(1-piperidinyl)butoxyl]-1(2h)-isoquinolinone,
Dpq [MI],
1(2H)-Isoquinolinone, 3,4-dihydro-5-(4-(1-piperidinyl)butoxy)-,
5-(4-(Piperidin-1-yl)butoxy)-3,4-dihydroisoquinolin-1(2H)-one,
ACMC-20emwb,
SCHEMBL214027,
BDBM27502,
CTK0F6063,
DTXSID10433229,
ZINC1546076,
MFCD01866274,
AKOS007930175,
KS-0000187B,
AC-10288,
RT-014944,
J-005648,
5-[4-(piperidin-1-yl)butoxy]-1,2,3,4-tetrahydroisoquinolin-1-one,
32Z,
PARP Inhibitor III, DPQ,
CID9948349,
C108729,
5-(4-piperidin-1-ylbutoxy)-3,4-dihydro-2H-isoquinolin-1-one,
5-[4-(1-piperidyl)butoxy]-3,4-dihydro-2H-isoquinolin-1-one,
3,4-dihydro-5-[4-(1-piperidinyl)butoxy]-1(2h)-isoquinolinone,